/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

W

Walid Fakhouri

Eli Lilly (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

49

Papers

353

Citations

10

h-index

11

i10-index

Walid Fakhouri is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 10, co-authored 42 publications.

Research Topics

Rheumatoid Arthritis Research and Therapies Systemic Lupus Erythematosus Research Chronic Lymphocytic Leukemia Research Autoimmune and Inflammatory Disorders Research Biosimilars and Bioanalytical Methods

Papers by this author

works

Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

2019 · Arthritis Research & Therapy · 26 citations

https://doi.org/10.1186/s13075-019-2030-8

Peter M. ten Klooster Letty G. A. Versteeg Martijn A. H. Oude Voshaar Inmaculada de la Torre

The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

2022 · Rheumatology and Therapy · 15 citations

https://doi.org/10.1007/s40744-022-00500-6

Rieke Alten Gerd R Burmester Marco Matucci‐Cerinic Jean‐Hugues Salmon

Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain

2024 · Future Oncology · 2 citations

https://doi.org/10.1080/14796694.2024.2368455

Isabel Blancas Jessica Grosjean R. Pedersini Carlotta Buzzoni

Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis

2021 · Advances in Therapy · 1 citations

https://doi.org/10.1007/s12325-021-01641-w

Walid Fakhouri Christophe Sapin Thorsten Holzkaemper Inmaculada de la Torre

A risk scoring system to predict coronary stent thrombosis

2017 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.4737235

Nikesh Malik Amerjeet Banning Mark Belger Walid Fakhouri

Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study

2025 · BMC Cancer · 0 citations

https://doi.org/10.1186/s12885-025-14526-w

Judy King Walid Fakhouri Rosalind Jarvis Waleed Badreldin

Research topics

topics

Rheumatoid Arthritis Research and Therapies

Systemic Lupus Erythematosus Research

Chronic Lymphocytic Leukemia Research

Autoimmune and Inflammatory Disorders Research

Biosimilars and Bioanalytical Methods

Chat about Author

Papers

Chat

Click to start Chat